Equity in Cardio-Oncology Care and Research

Published: June 28, 2023

equity in cardio-oncology
  • Cardiovascular disease (CVD) has become a leading cause of non-malignant morbidity and mortality in patients with cancer in the United States, however disparately high mortality risk following a cancer diagnosis is seen among females and those from underrepresented racial and ethnic groups.
  • Inequities in cardio-oncology are defined as differences in the optimal allocation of cardio-protective medications, surveillance, and development of adverse outcomes related to cancer therapy-related cardiac disease or outcomes between groups of different race, ethnicity, socioeconomic status, sexual orientation, and gender identity.
  • The multidisciplinary scientific statement provides practical strategies for reducing inequity in cardio-oncology and aims to move toward equity.